• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The effect of three dose levels of ICS 205-930 (a selective 5HT-3 antagonist) on cisplatin-induced nausea and vomiting.

作者信息

Seinen H, Zonnenberg B A, Tjia P, Neijt J P

机构信息

Department of Oncology, Utrecht University Hospital, The Netherlands.

出版信息

Eur J Cancer Clin Oncol. 1989 Sep;25(9):1333-5. doi: 10.1016/0277-5379(89)90081-3.

DOI:10.1016/0277-5379(89)90081-3
PMID:2806357
Abstract
摘要

相似文献

1
The effect of three dose levels of ICS 205-930 (a selective 5HT-3 antagonist) on cisplatin-induced nausea and vomiting.三种剂量水平的ICS 205-930（一种选择性5-羟色胺-3拮抗剂）对顺铂引起的恶心和呕吐的影响。
Eur J Cancer Clin Oncol. 1989 Sep;25(9):1333-5. doi: 10.1016/0277-5379(89)90081-3.
2
On-demand antiemetic treatment with the serotonine antagonist tropisetron in cisplatin-treated cancer patients.在接受顺铂治疗的癌症患者中使用血清素拮抗剂托烷司琼进行按需止吐治疗。
Anticancer Drugs. 1994 Aug;5(4):410-8. doi: 10.1097/00001813-199408000-00004.
3
Prospective randomized comparison of tropisetron with and without dexamethasone against high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting.托烷司琼联合与不联合地塞米松对比大剂量甲氧氯普胺预防顺铂所致急性和迟发性恶心呕吐的前瞻性随机对照研究
Am J Clin Oncol. 1999 Apr;22(2):126-30. doi: 10.1097/00000421-199904000-00004.
4
Antiemetic action of 5-HT3 receptor antagonists: review of preclinical and clinical results with ICS 205-930.5-羟色胺3受体拮抗剂的止吐作用：ICS 205-930的临床前和临床结果综述
Cancer Treat Rev. 1990 Sep;17(2-3):301-5. doi: 10.1016/0305-7372(90)90061-j.
5
[Tropisetron hydrochloride in preventing and treating chemotherapy-induced nausea and vomiting: a phase II, randomized, multicenter, double-blinded, comparative clinical trial].
Ai Zheng. 2007 Aug;26(8):870-3.
6
Tropisetron (ICS 205-930): a selective 5-hydroxytryptamine antagonist.
Eur J Cancer. 1993;29A Suppl 1:S30-2. doi: 10.1016/s0959-8049(05)80257-6.
7
[Prevention and treatment of postoperative nausea and postoperative vomiting with tropisetron].
Anasthesiol Intensivmed Notfallmed Schmerzther. 1997 Oct;32(10):628-31. doi: 10.1055/s-2007-995122.
8
Three years' experience with tropisetron in the control of nausea and vomiting in cisplatin-treated patients.
Drugs. 1992;43 Suppl 3:6-10. doi: 10.2165/00003495-199200433-00004.
9
Efficacy and tolerability of tropisetron and dexamethasone in the control of nausea and vomiting induced by cisplatin.
Ann Oncol. 1993;4 Suppl 3:31-4. doi: 10.1093/annonc/4.suppl_3.s31.
10
A study evaluating the efficacy and tolerability of tropisetron in combination with dexamethasone in the prevention of delayed platinum-induced nausea and emesis.一项评估托烷司琼联合地塞米松预防铂类药物所致迟发性恶心和呕吐的疗效及耐受性的研究。
Cancer. 1998 Sep 1;83(5):1022-32.

引用本文的文献

1
Benefits and risks of newer treatments for chemotherapy-induced and postoperative nausea and vomiting.新型化疗诱导性和术后恶心呕吐治疗方法的益处与风险
Drug Saf. 2003;26(4):227-59. doi: 10.2165/00002018-200326040-00003.
2
Tropisetron. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential as an antiemetic.
Drugs. 1993 Nov;46(5):925-43. doi: 10.2165/00003495-199346050-00009.
3
5-HT3 receptor antagonists. An overview of their present status and future potential in cancer therapy-induced emesis.5-羟色胺3受体拮抗剂。其在癌症治疗引起的呕吐方面的现状及未来潜力概述
Drugs. 1991 Oct;42(4):551-68. doi: 10.2165/00003495-199142040-00002.
4
Compassionate use of a 5-HT3-receptor antagonist, tropisetron, in patients refractory to standard antiemetic treatment.在对标准止吐治疗无效的患者中同情使用5-羟色胺3（5-HT3）受体拮抗剂托烷司琼。
Drugs. 1992;43 Suppl 3:27-32. doi: 10.2165/00003495-199200433-00007.
5
Tropisetron. A review of the clinical experience.托烷司琼。临床经验综述。
Drugs. 1992;43 Suppl 3:11-22. doi: 10.2165/00003495-199200433-00005.